MedTrace Logo

Impact of Anticipated Regret Incorporation Into Patient Decision Aids

NCT02563808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2023-04-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the impact of incorporating "anticipated regret " into standard patient decision aids. Participants in the Wharton Behavioral Lab will be administered a standard patient decision aid and an "anticipated regret" augmented decision aid. Participants will complete a computerized survey about their experiences with each version, and their answers will be assessed for potential differences associated with the incorporation of "Anticipated Regret."

Conditions

  • Regret

Interventions

OTHER

Standard Decision Aid

Females will receive standard decisions aid for early stage breast cancer.

OTHER

Post-surgical Regret Decision Aid

Females will receive anticipated regret-augmented version for early breast cancer.

Sponsors & Collaborators

Principal Investigators

  • Lee Fleisher, MD · UPenn, Chairman, Anesthesiology & Critical Care

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02563808 on ClinicalTrials.gov